Prot #ATOS-Z-201: A Randomized Phase 2 Non-inferiority Trial of (Z)-endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment for Premenopausal Women with ER+/HER2- Breast Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date1/31/241/31/27

Funding

  • Mayo Clinic (Prot #ATOS-Z-201 // Prot #ATOS-Z-201)
  • Atossa Genetics, Inc. (Prot #ATOS-Z-201 // Prot #ATOS-Z-201)